Status:

UNKNOWN

Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

Lead Sponsor:

KK Women's and Children's Hospital

Collaborating Sponsors:

Duke-NUS Graduate Medical School

National University Hospital, Singapore

Conditions:

COVID-19

Eligibility:

All Genders

1-90 years

Phase:

PHASE1

PHASE2

Brief Summary

The overall objective of this project is to develop an emergent treatment protocol using adoptive T-cell therapy for the treatment of severe COVID-19. The central hypothesis is that SARS-CoV-2 specifi...

Detailed Description

A novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of Coronavirus Disease 2019 (COVID-19). Currently, no vaccine has been proven to be effective. While waiting for vacci...

Eligibility Criteria

Inclusion

  • Age 1 to 90 years
  • Tested positive for SARS-CoV-2 \<72 hours prior to enrolment
  • Predicted to have high chance of mortality:
  • Group 1: Severe disease, defined by one or more of the following:
  • Dyspnea
  • Respiratory frequency ≥ 30/min
  • Blood oxygen saturation ≤ 93%
  • Partial pressure of arterial oxygen to fraction of inspired oxygen ratio \< 300
  • Lung infiltrates \> 50% within 24 to 48 hours
  • Respiratory failure
  • Septic shock
  • Multiple organ dysfunction or failure
  • Group 2: Mild to moderate disease, at high risk of progression to severe disease. For example,
  • Age \> 65 years
  • Chronic health conditions such as chronic lung disease, cardiovascular disease, diabetes mellitus, obesity, end-stage renal disease or liver disease

Exclusion

  • Rapidly progressive disease with anticipated life-expectancy \<72 hours
  • Receiving steroid (\>0.5mg/kg methylprednisolone equivalent)
  • Pregnancy
  • Breastfeeding

Key Trial Info

Start Date :

July 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2022

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT04457726

Start Date

July 1 2020

End Date

December 1 2022

Last Update

July 7 2020

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Changi General Hospital

Singapore, Singapore

2

KK Women's and Children's Hospital

Singapore, Singapore

3

National University Hospital

Singapore, Singapore

4

Sengkang General Hospital

Singapore, Singapore

Part Two of Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 | DecenTrialz